SP

Steve Paul

Development and Chief Scientific Officer at Karuna Therapeutics

United States

Overview

Work Experience

KT

Karuna Therapeutics

  • President of Research & Development and Chief Scientific Officer

    2023 - Current

Karuna Therapeutics, Inc

  • CEO and Chairman of the Board

    2018

VT

Voyager Therapeutics, Inc.

  • Senior Advisor, Co-founder and Board Member

    2018

Education

Investments

Rapport Therapeutics

Series A

Total Funding: $250M

Karuna Therapeutics

Series A

Total Funding: $110M

SAGE Therapeutics

Series C

Total Funding: $58M

Voyager Therapeutics

Series A

Total Funding: $45M

Relevant Websites